These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31943331)

  • 1. CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale.
    Lefferts JA; Loehrer AP; Yan S; Green DC; Deharvengt SJ; LeBlanc RE
    J Cutan Pathol; 2020 Jun; 47(6):541-547. PubMed ID: 31943331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic melanoma with sarcomatoid dedifferentiation.
    Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
    Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer.
    Kriegsmann M; Kriegsmann K; Harms A; Longuespée R; Zgorzelski C; Leichsenring J; Muley T; Winter H; Kazdal D; Goeppert B; Warth A
    Diagn Pathol; 2018 Sep; 13(1):68. PubMed ID: 30205833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity].
    Xia Q; Chang XN; Huang B; Li XF; Luo DJ; Wang QJ; Jiang MT; Fan J; Zhou DW
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):837-842. PubMed ID: 39103266
    [No Abstract]   [Full Text] [Related]  

  • 5. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
    Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
    Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma.
    Chung J; Shevchenko A; Lee JB
    J Cutan Pathol; 2021 Jul; 48(7):943-947. PubMed ID: 33675557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.
    Rupp NJ; Rechsteiner M; Freiberger SN; Lenggenhager D; Urosevic M; Burger IA; Rushing EJ; Mihic-Probst D
    Virchows Arch; 2018 Oct; 473(4):517-521. PubMed ID: 29785541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
    Tran TAN; Linos K; de Abreu FB; Carlson JA
    Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
    Chen SX; Eichenfield DZ; Orme C; Hinds B
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.
    Kasago IS; Chatila WK; Lezcano CM; Febres-Aldana CA; Schultz N; Vanderbilt C; Dogan S; Bartlett EK; D'Angelo SP; Tap WD; Singer S; Ladanyi M; Shoushtari AN; Busam KJ; Hameed M
    Mod Pathol; 2023 Aug; 36(8):100165. PubMed ID: 36990277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing.
    Valiga AA; Fuller CG; Doyle JA; Lee JB
    Am J Dermatopathol; 2022 Apr; 44(4):282-286. PubMed ID: 34726188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity.
    Parra O; Bridge JA; Busam KJ; Shalin SC; Linos K
    J Cutan Pathol; 2021 Jul; 48(7):915-924. PubMed ID: 33586183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME Expression Is a Useful Tool in the Diagnosis of Primary and Metastatic Dedifferentiated and Undifferentiated Melanoma.
    Hornick JL; Plaza JA; Mentzel T; Gru AA; Brenn T
    Am J Surg Pathol; 2023 Dec; 47(12):1390-1397. PubMed ID: 37727938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of MITF, SOX10, MART-1, and R21 Immunostaining for the Diagnosis of Residual Melanoma In Situ on Chronically Sun-Damaged Skin.
    Mu EW; Quatrano NA; Yagerman SE; Ratner D; Meehan SA
    Dermatol Surg; 2018 Jul; 44(7):933-938. PubMed ID: 29419543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Metastatic Melanoma:  Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1.
    Zand S; Buzney E; Duncan LM; Dadras SS
    Am J Clin Pathol; 2016 Sep; 146(3):353-60. PubMed ID: 27515936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.